Of the 27 speciality drugs approved by the Food and Drug
Administration in 2014, nine were approved for the treatment
of cancer or cancer-related conditions. FDA approvals in the
first quarter of 2015 included three oral cancer medications.
Additional approvals are expected for new cancer treatments
before the end of the year. In the following article, Sandra
Lottes, PharmD, Vice President, Global Clinical Development
& Operations, United BioSource Corporation (UBC) gives us
an insight into oncology.